AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
BioLINCC (a data-sharing platform funded by the National Institutes of Health) · Vivli · 2018
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Vivli · Vivli · dataset · 2018
Abstract
This study will test the effectiveness of warfarin in patients with IPF. Approximately 256 patients will be randomized 1:1 to either warfarin or placebo. Patients will return at week 1 for a safety review and every 16 weeks for 48 weeks. The primary endpoint in the study is the time to either death, non-bleeding/non-elective hospitalization, or a drop of greater than 10% in forced vital capacity (FVC) from baseline.
Open the resolved locator · 10.25934/00000091
Metadata licence: OpenAlex metadata (CC0)